Adjuvant Therapy

Adjuvant Therapy is a type of cancer treatment administered after primary curative-intent therapy to eliminate residual micrometastatic disease and reduce the risk of tumor recurrence within the academic domains of Breast Oncology, Cutaneous Oncology, and Medical Oncology.

11.8K

Publications

958.3K

Citations

58.7K

Authors

7.1K

Institutions

Publications per year

2017–2026

3.2K

Authors

58.7K

  1. NW
    Norman Wolmark

    NSABP Foundation, United States

    156 publications · 58K citations

    88

    h-index

  2. GN
    Gabriel N. Hortobágyi

    The University of Texas MD Anderson Cancer Center, United States

    147 publications · 22.6K citations

    72

    h-index

  3. RD
    Richard D. Gelber

    Dana-Farber Cancer Institute, United States

    127 publications · 37.2K citations

    70

    h-index

  4. EP
    Eric P. Winer

    Dana-Farber Cancer Institute, United States

    120 publications · 27.9K citations

    64

    h-index

  5. MP
    Martine Piccart

    Institut Jules Bordet, Belgium

    140 publications · 30.1K citations

    62

    h-index

1–5 of 58.7K

Venues

  1. Journal of Clinical Oncology

    1.3K publications · 194.4K citations

    235

    h-index

  2. Annals of Oncology

    429 publications · 42.4K citations

    103

    h-index

  3. Cancer

    435 publications · 37.1K citations

    102

    h-index

  4. New England Journal of Medicine

    NEJM · 118 publications · 130.1K citations

    98

    h-index

  5. The Lancet Oncology

    138 publications · 40.7K citations

    96

    h-index

1–5